trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['enhertu', 'lung', 'astrazeneca']
#astrazeneca reported that #enhertu continues to demonstrate clinically meaningful #tumour response in patients with #her2 mutant #metastatic #nonsmallcelllungcancer #esmo22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.